Toshiba developed the diagnosis method together with the National Cancer Center Research Institute and Tokyo Medical University, and hopes to commercialize it in "several years" after starting a trial next year.
The method is designed to examine the types and concentration of microRNA molecules secreted in blood from cancer cells. Toshiba has developed a chip and a small device that can conduct the diagnosis in less than two hours. A blood test using it is expected to cost about more than 180 US dollars or less.
